XML 12 R1.htm IDEA: XBRL DOCUMENT v3.25.2
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2025
Jul. 29, 2025
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2025  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q2  
Trading Symbol BBIO  
Entity Registrant Name BridgeBio Pharma, Inc.  
Entity Central Index Key 0001743881  
Current Fiscal Year End Date --12-31  
Entity Filer Category Large Accelerated Filer  
Entity Current Reporting Status Yes  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity File Number 001-38959  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 84-1850815  
Entity Address, Address Line One 3160 Porter Drive  
Entity Address, Address Line Two Suite 250  
Entity Address, City or Town Palo Alto  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94304  
City Area Code 650  
Local Phone Number 391-9740  
Entity Common Stock, Shares Outstanding   191,168,504
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Title of 12(b) Security Common Stock, par value $0.001 per share  
Security Exchange Name NASDAQ